Improving bio-emergency response for the U.S.
and its allies.
Born from a partnership between private industry and the Office of the Assistant Secretary for Preparedness and Response (ASPR) with the U.S. Department of Health and Human Services (HHS), the RAPID Consortium looks to explore how modern drug packaging and delivery technologies, such as Blow-Fill-Seal, can strengthen notional security and emergency response.
Work directly with the U.S. Government and leading companies
This offers member organizations many excellent opportunities for leadership, research, and growth, including:
- Submit and join R&D projects that further U.S. Government surge response needs
- Network with leading organizations and leaders
- Shape the future of Blow-Fill-Seal for bio-emergency response
- Be a recognized leader in national health
- Co-own intellectual property your organization helps
develop with the government
Demonstrate your organization’s leadership
Who joins the RAPID Consortium? Companies and organizations that want to be on the front lines and cutting edge of national and international surge response for medicines and vaccines.
This includes pharmaceutical companies, contract manufacturers, raw material producers, global health organizations, medical devices companies, fill and finish machine developers, and more.
Contact the RAPID Consortium to learn more about joining.
Working together to advance manufacturing
For example, today with Government support, ApiJect (a founding member of RAPID) is advancing the use of Blow-Fill-Seal, a 60+ year old plastics packaging technology, for injectable pharmaceuticals. The goal is to see how this established technology can be used in a new space – improving the speed and scale of packaging of injectable drugs for emergency response.